Trial
NCT06910384
A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
New England Cell Therapeutics, Inc.
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
STR04
Why stopped
organizational restructure
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18